Unispital_USZ

Trusted

http://www.usz.ch/

Last activity: 27.06.2026

Active

Categories: CareHealthTechUniversity

Für Notfälle
Brauchen Sie dringenden Rat oder Hilfe, so wenden Sie sich bitte an die Telefonnummer 144 (medizinische Notfälle) oder 143 (Sorgentelefon bei Suizidgedanken).

Für medizinische Angelegenheiten
Haben Sie eine Frage zu einem medizinischen Anliegen, wenden Sie sich an unsere Onlineberatung. Die Onlineberatung bietet einfachen Zugang zum hochspezialisierten Wissen des UniversitätsSpitals Zürich. Ohne Anmeldung können Sie für CHF 75.- eine medizinische Frage stellen und eine fundierte Antwort vom USZ erhalten.
http://www.usz.ch/onlineberatung

Für private Fragen
Ihre Posts sind öffentlich und können von anderen gelesen werden. Für private Fragen können Sie uns auf [email protected] schreiben.

Twitter Facebook LinkedIn Youtube Email

Likes

12.53K

Followers

3.96K

Website visits

616.8K /mo.

Mentions

Overview

Location

Switzerland, Zurich, Stettbach

Employees

5001-10000

Phone

+41 44 255 11 11

Founded date

1204

Mentions in press and media 28

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Mar 12, 2026	EIC Backs Pregnolia's Groundbreaking Preterm Birth Prediction System	Pregnolia secured significant EIC Accelerator funding, propelling its advanced diagnostic system for preterm birth prediction. The Swiss medtech measures cervical stiffness, a crucial biomarker, aiming to reduce premature deliveries. This i...
Mar 11, 2026	Pregnolia secures equity funding to bring preterm birth prediction to clinical practice	In Switzerland, up to seven out of every 100 babies are born prematurely. For the affected newborns and their mothers, this represents an enormous emotional burden. This challenge has been at the heart of Sabrina Badir's work since her res...
Feb 19, 2026	Femtech FimmCyte closes wide-ranging agreement with Richter	FimmCyte, founded in 2022, is a biotech spin-off from the University of Zurich and University Hospital Zurich. The company is advancing an antibody pipeline for women’s health, with an initial focus on endometriosis, a complex fibro-inflam...
Feb 18, 2026	Elicera Therapeutics to present ipdated CARMA study data on March 6, 2026, at the 10th Zurich Immuno-Oncology Conference	Elicera Therapeutics to present ipdated CARMA study data on March 6, 2026, at the 10th Zurich Immuno-Oncology Conference Wed, Feb 18, 2026 13:57 CET Report this content Gothenburg, February 18, 2026 – Elicera Therapeutics AB (publ), a clini...
Jan 22, 2026	Elicera Therapeutics’ CSO invited to present at multiple scientific conferences	Elicera Therapeutics’ CSO invited to present at multiple scientific conferences Thu, Jan 22, 2026 09:43 CET Report this content Gothenburg, January 22, 2024 – Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company de...
Jan 8, 2026	PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows	PathAI, a global leader in AI-powered pathology, announced a strategic collaboration with University Hospital Zurich (USZ) to deploy AISight Dx , PathAI’s CE-IVD digital pathology platform, together with AIM-TumorCellularity (AIM-TC) to sup...
Jan 6, 2026	Crans-Montana Inferno: New Year's Blaze Kills Dozens, Sparks Global Medical Crisis	A devastating New Year's Eve fire ripped through a crowded Crans-Montana ski resort bar, killing forty and severely injuring over a hundred. Sparklers on champagne bottles ignited the low ceiling, creating a rapid inferno. The catastrophe o...
2026	Dozens killed in fire at Swiss ski resort New Year party	CRANS-MONTANA: Around 40 people were killed and over 100 injured when a fire ripped through a crowded bar in the luxury Swiss ski resort town of Crans-Montana as young revellers rang in the new year, police said Thursday (Jan 1). Horrified ...
Dec 22, 2025	CHF 40,000 for new liquid biopsy of cancer, next-gen systemic risk intelligence for pharma, and microsized-mediated healthcare	CAPTAIM - Apheryon: Next-generation liquid biopsy of cancer Most cancer patients still lack access to personalized vaccines because traditional biopsies are invasive, risky, or unfeasible. This exclusion limits precision oncology and leaves...
Nov 14, 2025	Wyss Zurich celebrates its tenth anniversary with impressive results	The path from groundbreaking science to real-world applications is a long one. Wyss Zurich's goal is to bridge this valley of death between science funding and venture capital investments and to accelerate the translation of research into ...
Oct 3, 2025	Deeptech startups impress juries across Switzerland	Cradle and Oxyle have been name Norrsken VC’s Impact/100, an annual ranking by the Norrsken Foundation, which recognizes the 100 most promising impact startups from all over the world. Cradle Bio uses generative AI to help scientists desig...
Sep 4, 2025	Johnson & Johnson acquires Obaris	OBaris AG is a preclinical-stage spin-off from ETH Zurich and the University Hospital Zurich (USZ) founded in 2024. Following six years of research, the startup has developed a technology platform, OctoPatch, a painless suction patch that ...
Aug 13, 2025	ETH Zurich Develops 3D Printed Heart Patch to Support Tissue Regeneration	A research team from the Swiss university ETH Zurich and the University Hospital of Zurich, led by Professors Robert Katzschmann and Omer Dzemali, has created a new 3D heart patch intended for implantation inside the heart. Published recent...
Jun 4, 2025	ZuriEV gets financial boost to scale blood test for brain cancer diagnosis	Despite advances in oncology, early detection of aggressive brain tumors—such as glioblastoma and brain metastases—remains a major gap. Current tools are often invasive, expensive, and fail to identify disease until symptoms have already p...
May 13, 2025	iotaMotion Announces First Use of Robotic-Assisted Cochlear Implant Technology Outside the U.S. as Part of Clinical Investigation in Switzerland	ST. PAUL, Minn., May 14, 2025 /PRNewswire/ -- iotaMotion, Inc., a leader in robotic-assisted systems for cochlear implant surgery, today announced the first use of the iotaSOFT® Insertion System outside of the United States. The technology ...
Apr 8, 2025	University Hospital Zurich's Health Innovation Hub expands portfolio	The Health Innovation Hub (HIH) is the startup support arm of the Innovation & Startup Center (ISC) of the USZ, which was founded by the USZ in 2018. The aim of the ISC is to promote entrepreneurship and innovation in healthcare at and...
Feb 26, 2025	Karolinska University Hospital ranks as the fifth-best hospital in the world and the best in Europe in a global ranking	Karolinska University Hospital ranks as the fifth-best hospital in the world and the best in Europe in a global ranking Wed, Feb 26, 2025 16:07 CET Report this content Karolinska University Hospital is ranked as the fifth-best hospital in t...
Dec 30, 2024	PreComb completes Series A fundraising to drive commercialization	PreComb’s technology is poised to transform precision oncology by enabling the rapid discovery and delivery of personalized cancer treatments. With its proprietary screening and automation technology, the Swis biotech company speeds up the...
Nov 6, 2024	Alivion taps into the health market with breath analysis technology	SmartSelect™, Alivion’s proprietary technology developed over 10 years at the ETH Zurich, uses nanostructured gas sensors, filter technology and smart algorithms to identify substances in body’s breath and liquids. This offers near real-ti...
Oct 3, 2024	Carity lanciert Blended Care-Lösung für Herz-Reha	Nach einem sogenannten kardialen Ereignis, sprich einem Herzinfarkt oder bei Herzinsuffizienz, ist es wichtig, dass mittels geeigneter körperlicher Bewegung der Herzmuskel wieder trainiert wird, um seine Leistungsfähigkeit wieder zu verbes...
Apr 17, 2024	Study Shows Fitness Trackers, Smartphones Effective in Monitoring Multiple Sclerosis Progression	John Lopez, Tech Times 17 April 2024, 12:04 pm A recent study revealed a new approach to monitoring the progression of multiple sclerosis (MS) using everyday wearable technology. The study, conducted by researchers from ETH Zurich, Universi...
Oct 6, 2023	CITUS kicks-off entrepreneurial journey with a financial boost
Jun 1, 2022	Cancer Patient's Liver Preserved Outside the Body for 3 Days to Repair, Transplant is a Success After a Year	Isaiah Richard, Tech Times 01 June 2022, 02:06 am Usually, organs do not survive being out of the body for too long, especially if they are not put into special containers that will help them survive the transport from one place to another....
Jun 4, 2021	Novartis inks partnership agreement with Cellerys
Nov 6, 2017	CUTISS receives Swissmedic approval for Phase II trials
Sep 24, 2014	CTI supports the development of a prostate cancer risk stratification test
Mar 21, 2013	Augurix, ETHZ and University of Zürich to initiate joint research programme

Reviews 0

FAQ about Unispital_USZ

What has the press written about Unispital_USZ?

Parsers VC has collected 28 articles mentioning Unispital_USZ, among them “EIC Backs Pregnolia's Groundbreaking Preterm Birth Prediction System” (Mar 12, 2026) and “Pregnolia secures equity funding to bring preterm birth prediction to clinical practice” (Mar 11, 2026).

Is Unispital_USZ still active?

Yes, Unispital_USZ is active; its latest activity on Parsers VC dates from Jun 27, 2026.